Alzheimer’s Drug Slows Cognitive Decline in Key Study

Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.

from NYT > Health https://ift.tt/1IaMP2l
via health&fitness